Beyond Dawlish

South Korea Vaccine Market Overview

Base Year: 2023

Historical Years: 2018-2023

Forecast Years: 2024-2032

Market Growth Rate: 4.14% (2024-2032)

 

The proactive stance of the governing body in supporting the biotechnology and pharmaceutical sectors is propelling market growth in South Korea. According to the latest report by IMARC Group, the South Korea vaccine market size is projected to exhibit a growth rate (CAGR) of 4.14% during 2024-2032.

 

Download sample copy of the Report: https://www.imarcgroup.com/south-korea-vaccine-market/requestsample

 

South Korea Vaccine Industry Trends and Drivers:

 

The South Korea vaccine market is expanding rapidly, owing to several key factors. Primarily, the market is driven by the growing public awareness of vaccine-preventable diseases as well as efforts of government bodies to increase vaccination coverage. Besides this, the market is supported by the expansion of national immunization programs, which provide vaccines against diseases such as influenza, hepatitis, and human papillomavirus (HPV). In line with these factors, local production capabilities, coupled with strong research and development (R&D) investments, also contribute significantly to the growth of the South Korea vaccine market. Additionally, the aging population and increasing prevalence of chronic diseases have heightened the demand for adult vaccination to prevent complications from infections.

 

Emerging trends in the South Korea vaccine market include the development and adoption of next-generation vaccines, such as mRNA-based platforms, which gained prominence during the COVID-19 pandemic. Moreover, the focus on combination vaccines, which reduce the number of injections needed while providing broader protection, is also rising. In addition to these factors, South Korea’s growing biopharmaceutical sector is leveraging advanced technologies for faster vaccine development and manufacturing. Furthermore, the rising collaboration between public and private entities for vaccine development and distribution ensures the timely availability of immunizations. Apart from this, the increasing export opportunities and a focus on global health initiatives are expected to bolster the market. Consequently, the combination of these factors is anticipated to propel the expansion of the South Korea vaccine market in the coming years.

 

We explore the factors propelling the South Korea vaccine market growth, including technological advancements, consumer behaviors, and regulatory changes.

 

South Korea Vaccine Industry Segmentation:

 

The report has segmented the market into the following categories:

 

 Product Type Insights:

• Multivalent Vaccine
• Monovalent Vaccine

Treatment Type Insights:

• Preventive Vaccine
• Therapeutic Vaccine

Technology Insights:

• Conjugate Vaccines
• Inactivated and Subunit Vaccines
• Live Attenuated Vaccines
• Recombinant Vaccines
• Toxoid Vaccines
• Others

Route of Administration Insights:

• Intramuscular and Subcutaneous Administration
• Oral Administration
• Others

Patient Type Insights:

• Pediatric
• Adult

Indication Insights:

• Bacterial Diseases
  • Meningococcal Disease
  • Pneumococcal Disease
  • Diphtheria/Tetanus/Pertussis (DPT)
  • Tuberculosis
  • Haemophilus Influenzae (Hib)
  • Typhoid
  • Others
• Viral Diseases
  • Hepatitis
  • Influenza
  • Human Papillomavirus (HPV)
  • Measles/Mumps/Rubella (MMR)
  • Rotavirus
  • Herpes Zoster
  • Varicella
  • Japanese Encephalitis
  • Rubella
  • Polio
  • Rabies
  • Dengue
  • Others

Distribution Channel Insights:

• Hospital Pharmacies
• Retail Pharmacies
• Institutional Sales
• Others

End User Insights:

• Hospitals
• Clinics
• Vaccination Centers
• Academic and Research Institutes
• Others

Regional Insights:

• Seoul Capital Area
• Yeongnam (Southeastern Region)
• Honam (Southwestern Region)
• Hoseo (Central Region)
• Others

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

 

Key highlights of the Report:

• Market Performance (2018-2023)
• Market Outlook (2024-2032)
• COVID-19 Impact on the Market
• Porter’s Five Forces Analysis
• Strategic Recommendations
• Historical, Current, and Future Market Trends
• Market Drivers and Success Factors
• SWOT Analysis
• Structure of the Market
• Value Chain Analysis
• Comprehensive Mapping of the Competitive Landscape

 

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

 

About Us:

 

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include a thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

 

Contact Us:  

 

IMARC Group 

134 N 4th St. Brooklyn, NY 11249, USA 

Email: sales@imarcgroup.com 

Tel No:(D) 91 120 433 0800 

United States: 1-631-791-1145